Company profile: Azzur
1.1 - Company Overview
Company description
- Provider of pharmaceutical, biotechnology, and medical device manufacturing; cGMP-compliant cleanroom space, warehousing, and material management; GxP advisory and consulting; commissioning, qualification, and process/cleaning validation; temperature-mapping equipment rental; aseptic and GxP training via on-site and turnkey centers; and IT advisory services.
Products and services
- GXP Advisory and Consulting: Delivers GxP-compliant consulting programs across the product lifecycle, focusing on quality assurance, regulatory compliance, and validation services for pharmaceuticals, biotechnology, and medical devices
- Qualification and Validation: Executes regulatory-grade commissioning and qualification, process validation, and cleaning validation to ensure life science organizations meet regulatory standards
- Azzur Cleanrooms on Demand™: Supplies cGMP-compliant cleanroom space with warehousing and material management for life science companies, eliminating facility ownership or CMO reliance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Azzur
Irisys
HQ: United States
Website
- Description: Provider of contract pharmaceutical product development and manufacturing services, offering pharmaceutical research and development and formulation development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Irisys company profile →
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
TD2
HQ: United States
Website
- Description: Provider of oncology-focused contract research services, offering data-driven clinical study management for Phase I–III trials; preclinical tools with 400+ cancer models to maximize data value and predict patient response; regulatory support (IND readiness, development, filings, FDA interactions); PK/ADME assays; and CDX models including NCI-H1963 (lung) and CCRF-CEM (T-ALL) to accelerate translational oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TD2 company profile →
Exploristics
HQ: United Kingdom
Website
- Description: Provider of biosimulation software and biostatistics services for designing, analyzing, and reporting clinical trials and real studies. Offers KerusCloud, a simulation platform for tailored study design; biostatistics and statistical consulting; data science services using advanced analytics, machine learning, and predictive modeling; and an Analytics Academy for training in statistical analysis and programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exploristics company profile →
Leukocare
HQ: Germany
Website
- Description: Provider of biopharmaceutical formulation development services operating at the interface of drug substance and drug product, combining bioinformatics, artificial intelligence and data science. Offerings include drug substance characterization, developability assessment, particle characterization, stability studies, and in silico analytics to optimize and accelerate development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Leukocare company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Azzur
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Azzur
2.2 - Growth funds investing in similar companies to Azzur
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Azzur
4.2 - Public trading comparable groups for Azzur
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →